Webinar

Rapid Leukemia Classification Using Nanopore Sequencing

Now Available On Demand

Nanopore sequencing technology can generate high-resolution transcriptomic data in real-time and at a low cost, which heralds new opportunities for molecular medicine.

We demonstrated the potential clinical utility of real-time transcriptomic profiling by processing RNA sequencing data from childhood acute lymphoblastic leukemia (ALL) clinical research samples on-the-fly with a trained neural network classifier.

Our major findings were that the neural network was able to accurately classify 11 out of 12 leukemia samples, with as little as 5 minutes of sequencing needed to accurately classify ALL.

Attend this webinar to learn:
  • How gene expression profiles could be used for accurate classification of ALL molecular subtypes
  • The potential impact of nanopore sequencing on the speed of ALL
  • The benefits of scalability afforded by the Oxford Nanopore platform

Speaker Information:

Melanie Round Image - New
Mélanie Sagniez
PhD student
CHU Sainte-Justine Research Center and Department of Biochemistry and Molecular Medicine, Université de Montréal
Attend this webinar to learn:
  • How gene expression profiles could be used for accurate classification of pediatric ALL molecular subtypes
  • How nanopore sequencing shows the potential to greatly reduce the turnaround time for ALL diagnosis in the future
  • The benefits of scalability afforded by the Oxford Nanopore platform

Watch for FREE Now!

Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.